RBC Capital Maintains Outperform on Thermo Fisher Scientific, Lowers Price Target to $579
Portfolio Pulse from Benzinga Newsdesk
RBC Capital analyst Conor McNamara has maintained an 'Outperform' rating on Thermo Fisher Scientific (NYSE:TMO) but lowered the price target from $657 to $579.
October 26, 2023 | 5:52 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Thermo Fisher Scientific's price target has been lowered by RBC Capital from $657 to $579, although the 'Outperform' rating is maintained.
The lowering of the price target by RBC Capital could potentially create a negative sentiment among investors, which might put downward pressure on the stock price. However, the maintained 'Outperform' rating indicates that the analyst still sees potential upside for the stock, which could counterbalance the negative sentiment.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100